-
Jul 18, 2023, 4:00 pm130 pts
Slashdot
An experimental drug can slow progression of Alzheimer's disease in those who start taking it when the disease is still in its early stages. Nature: The drug, a monoclonal antibody called donanemab, does not improve symptoms. But among people who started taking it at the earliest stages of Alzheimer's, 47% had…
Trending Today on Tech News Tube
Tech News Tube is a real time news feed of the latest technology news headlines.
Follow all of the top tech sites in one place, on the web or your mobile device.
Follow all of the top tech sites in one place, on the web or your mobile device.
